Back to search
Diabetic Macular Edema (DME)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Macular Edema (DME) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Macular Edema (DME) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of the eye (call…
The main goal of this study is to find out how common certain eye diseases are in Germany and how they have changed over time. The diseases being studied are:…
The purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participan…
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
The goal of this clinical trial is to see if treatment with faricimab or biosimilar ranibizumab leads to different early imaging changes in adults with diabetic…
EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, r…
EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, r…